Safety and Immunogenicity Study of GX-19N, a COVID-19 Preventive DNA Vaccine in Healthy Adults

NCT04715997 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

185

Enrollment

INDUSTRY

Sponsor class

Conditions

SARS-CoV-2

Interventions

DRUG: GX-19N
DRUG: Placebo

Sponsor

Genexine, Inc.